Hermetica Superfood Encyclopedia
The Short Answer
Al-ruwag (Ocimum gratissimum) contains eugenol (up to 76% of essential oil), thymol, rosmarinic acid, and flavonoids such as luteolin and vicenin-2, which exert antioxidant, antimicrobial, and anti-inflammatory effects through free-radical scavenging and membrane disruption. Preclinical data demonstrate that aqueous extracts at 20–80 mg/mL significantly reduce H₂O₂-induced lipid peroxidation in HepG2 cells, and essential oil fractions achieve DPPH radical scavenging with an IC₅₀ of 3.9 μg/mL, though human clinical trials confirming respiratory efficacy remain absent.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary Keywordal-ruwag benefits
Al-ruwag — botanical close-up
Health Benefits
**Antioxidant Protection**
Rosmarinic acid, vicenin-2, and quercetin scavenge reactive oxygen species and reduce thiobarbituric acid reactive substances (TBARS) in oxidatively stressed hepatic cells, with measurable protection observed at extract concentrations of 20–80 mg/mL in vitro.
**Respiratory Support (Traditional)**
In Sudanese Arabic ethnomedicine, steam inhalation of boiled Al-ruwag leaves and leaf infusions are employed to relieve cough, bronchial congestion, and sinusitis, effects attributed to the volatile 1,8-cineole and eugenol content, which are known bronchodilatory and mucolytic agents in related species.
**Antimicrobial Activity**
Eugenol and thymol, the dominant essential oil constituents, disrupt microbial cell membranes by increasing permeability and dissipating proton motive force, conferring broad-spectrum antibacterial and antifungal activity documented in multiple in vitro disk-diffusion studies.
**Hepatoprotective Effects**
Ethanolic and aqueous extracts at 0–40 mg/kg in carbon tetrachloride (CCl₄)-induced rat liver injury models reduced hepatic steatosis, collagen deposition, and fibrosis while upregulating catalase activity, suggesting protection against oxidative hepatotoxicity.
**Anti-inflammatory Action**
Flavonoids including luteolin and apigenin, alongside phenolic acids such as caffeic and chlorogenic acid, inhibit pro-inflammatory mediator cascades, likely through suppression of cyclooxygenase and lipoxygenase pathways, though specific NF-κB or cytokine-level quantification in O. gratissimum studies remains limited.
**Antidiabetic Potential**
Traditional use for blood sugar management is supported by preliminary in vivo evidence suggesting leaf extracts may modulate glucose metabolism, possibly through alpha-glucosidase inhibition by flavonoid glycosides such as rutin and vitexin, though mechanistic clarity is lacking.
**Antihypertensive Properties**
Ethnopharmacological surveys across West and East Africa record use of leaf decoctions for hypertension, with terpenoids and flavonoids theorized to promote vasodilation; formal clinical evidence is absent, and this application awaits controlled investigation.
Origin & History
Natural habitat
Ocimum gratissimum, commonly called African basil or scent leaf, is native to tropical Africa, India, and South America, thriving in warm, humid climates with well-drained soils at low to mid elevations. In Sudan and across the Sahel, it is cultivated around homesteads and in kitchen gardens, where it is known regionally as Al-ruwag and harvested primarily for its aromatic leaves and essential oil. The plant grows as a perennial woody shrub reaching up to 1.5 meters, producing dense clusters of small white or pale-violet flowers, and is propagated easily from seed or stem cuttings across sub-Saharan Africa.
“Ocimum gratissimum has been integrated into the medicinal, culinary, and ritual practices of West African, East African, and South Asian communities for centuries, with its strong aromatic profile making it a distinguishing feature of traditional healing landscapes from Nigeria to Sudan to India. In the Sudanese Arabic tradition, the plant is known as Al-ruwag and occupies a specific role as a respiratory remedy, with healers and households preparing hot leaf decoctions and steam inhalations to manage coughs, chest tightness, and upper respiratory infections, a practice embedded in broader African ethnomedical frameworks that prioritize aromatic plants for pulmonary complaints. Across West Africa, particularly in Nigeria, Côte d'Ivoire, and Benin, the plant — locally called 'efirin' in Yoruba — is used simultaneously as a cooking herb in soups and as a medicine for fever, diarrhea, skin infections, and diabetes, reflecting its polyvalent cultural status. Ethnobotanical surveys conducted in the 20th and 21st centuries have systematically documented these oral traditions, providing the scholarly framework within which modern phytochemical investigations of the herb have been anchored.”Traditional Medicine
Scientific Research
The evidence base for Al-ruwag (Ocimum gratissimum) consists entirely of preclinical research — in vitro cell culture experiments and in vivo rodent models — with no published randomized controlled trials or other human clinical studies identified as of the current literature search. Key in vitro findings include statistically significant reductions in H₂O₂-induced TBARS in HepG2 hepatocyte cultures at extract concentrations of 20–80 mg/mL, and essential oil antioxidant IC₅₀ values of 3.9 μg/mL (DPPH assay) and 3.13 mg/mL (ABTS assay), indicating potent radical-scavenging capacity. Rodent hepatotoxicity models using CCl₄ administration demonstrated dose-dependent hepatoprotection at 0–40 mg/kg oral extract doses, with histological reductions in steatosis and fibrosis and measurable increases in hepatic catalase activity, though interspecies translation to humans is uncertain. The body of evidence is categorized as preliminary, and the traditional respiratory indication specifically lacks any controlled mechanistic or clinical investigation; phytochemical characterization studies are the most robust contribution of the current literature.
Preparation & Dosage
Traditional preparation
**Fresh Leaf Infusion (Traditional Tea)**
5–10 g) of fresh leaves steeped in 250 mL of boiling water for 10–15 minutes; consumed 1–2 times daily in Sudanese ethnomedicine for cough and respiratory congestion
A small handful (approximately .
**Steam Inhalation**
Fresh or dried leaves added to a bowl of boiling water; vapors inhaled under a towel for 5–10 minutes to relieve nasal and bronchial congestion, leveraging volatile eugenol and 1,8-cineole content.
**Aqueous Extract (Research Grade)**
0–40 mg/kg body weight in rodents; no equivalent human dose established via allometric scaling or clinical trial
Preclinical hepatoprotective studies used .
**Ethanolic Extract (Laboratory)**
20–80 mg/mL for antioxidant and cytoprotective assays; not directly applicable to oral supplementation without bioavailability data
Effective in vitro concentrations of .
**Essential Oil (Topical/Aromatic)**
Steam-distilled EO used at 0.1% concentration in antioxidant in vitro models; eugenol-dominant chemotypes (up to 76% eugenol) used topically or aromatically in traditional practice, with caution warranted due to eugenol's known dermal sensitization potential.
**Dried Leaf Powder**
Used in soups and condiment preparations in West Africa; no standardized supplemental dose exists, and commercial encapsulated forms are not widely available or studied.
**Standardization Note**
No commercial standardization to specific marker compounds (e.g., eugenol percentage or rosmarinic acid content) has been established; chemotype variation significantly affects potency.
Nutritional Profile
The leaves of Ocimum gratissimum provide modest macronutrients typical of aromatic leafy herbs, with primary nutritional significance arising from their dense phytochemical content rather than caloric contribution. Key bioactive phytochemicals include phenolic acids — rosmarinic acid, caffeic acid, chlorogenic acid, sinapic acid, ellagic acid, and L-chicoric acid — alongside flavonoids such as luteolin, apigenin, quercetin, rutin, kaempferol, vicenin-2, vitexin, isovitexin, and epicatechin, with total phenolic content varying substantially by geographic origin and extraction solvent. The essential oil fraction contributes eugenol (up to 76.01% in some chemotypes), thymol (up to 29.5%), γ-terpinene (up to 20.5%), p-cymene (up to 12.9%), 1,8-cineole (0.30–23.04%), carvacrol (0.20–8.40%), β-caryophyllene, α-pinene, β-pinene, limonene, and sesquiterpenes including α-trans-bergamotene and (Z,E)-α-farnesene. Micronutrients include ascorbic acid (vitamin C) and alpha-tocopherol (vitamin E), contributing to the plant's antioxidant capacity; tannins, alkaloids, terpenoids including oleanolic acid, and glycosides round out the phytochemical spectrum. Bioavailability of polyphenols is subject to gut microbiota metabolism, food matrix interactions, and individual variation; eugenol undergoes hepatic glucuronidation and sulfation, producing water-soluble metabolites with variable systemic distribution.
How It Works
Mechanism of Action
The antioxidant activity of Al-ruwag is driven primarily by phenolic acids (rosmarinic acid, caffeic acid, chlorogenic acid) and flavonoids (luteolin, quercetin, vicenin-2), which donate hydrogen atoms to neutralize free radicals and chelate transition metals, thereby reducing lipid peroxidation and upregulating endogenous antioxidant enzymes including catalase and superoxide dismutase in hepatic tissue. Eugenol and thymol, the dominant essential oil constituents, disrupt prokaryotic and fungal membrane integrity by intercalating into the phospholipid bilayer, increasing ion permeability, and collapsing the proton gradient necessary for ATP synthesis, accounting for the herb's documented antimicrobial properties. Anti-inflammatory effects are attributed to the capacity of luteolin, apigenin, and rosmarinic acid to suppress arachidonic acid cascade enzymes (cyclooxygenase-2 and 5-lipoxygenase), reducing prostaglandin and leukotriene synthesis, though direct binding affinity data for O. gratissimum isolates are not yet published. The bronchodilatory and expectorant actions traditionally ascribed to respiratory use are most plausibly mediated by 1,8-cineole, which at pharmacologically relevant concentrations inhibits airway smooth muscle contraction and stimulates mucociliary clearance, consistent with well-characterized mechanisms of this monoterpene in clinical studies of other eucalyptol-rich herbs.
Clinical Evidence
No human clinical trials have evaluated Al-ruwag (Ocimum gratissimum) for any indication, including its primary traditional use as a Sudanese respiratory remedy; all pharmacological outcome data derive from cell-based or animal experiments. Preclinical hepatoprotective studies in CCl₄-intoxicated rodents recorded histopathological improvements and catalase upregulation at 0–40 mg/kg doses, but effect sizes and p-values were not universally reported across publications, limiting meta-analytic synthesis. Antioxidant assay results (DPPH IC₅₀ = 3.9 μg/mL) are pharmacologically impressive but measured under in vitro conditions that do not account for absorption, distribution, metabolism, or excretion in living systems. Confidence in therapeutic claims for this ingredient remains low by evidence-based medicine standards; clinical translation of promising preclinical signals requires well-designed Phase I safety trials followed by controlled efficacy studies before therapeutic recommendations can be issued.
Safety & Interactions
Formal human toxicology data for Ocimum gratissimum are absent from the published literature, and no maximum safe dose, no-observed-adverse-effect level (NOAEL), or tolerable upper intake level has been established for any preparation form; preclinical rodent studies at 0–40 mg/kg showed no overt organ toxicity, but these findings cannot be directly extrapolated to human safety profiles. Eugenol, a dominant essential oil constituent (up to 76%), is a documented dermal and mucosal sensitizer at high concentrations and a known inhibitor of platelet aggregation, raising theoretical concerns about potentiation of anticoagulant and antiplatelet medications (e.g., warfarin, aspirin, clopidogrel) if the essential oil is ingested in pharmacological quantities. Thymol and carvacrol, present in some chemotypes, are metabolized via hepatic CYP450 enzymes and may theoretically interact with drugs sharing those metabolic pathways, though no pharmacokinetic drug interaction studies in humans have been conducted for this species specifically. Pregnancy and lactation safety is unestablished; given the herb's traditional classification as an emmenagogue in some regional practices and the uterine stimulant potential of eugenol reported in related Ocimum species, avoidance during pregnancy is prudent until controlled safety data are available.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
efirin (Yoruba)nchuanwu (Igbo)tree basilAl-ruwag (Newbouldia laevis)African basilclove basilOcimum gratissimumscent leafAl-ruwag
Frequently Asked Questions
What is al-ruwag used for in traditional Sudanese medicine?
In Sudanese Arabic ethnomedicine, Al-ruwag (Ocimum gratissimum) is primarily used as a respiratory remedy, with fresh or dried leaves prepared as hot infusions or steam inhalations to relieve cough, bronchial congestion, and upper respiratory infections. The therapeutic rationale is supported by the plant's content of 1,8-cineole and eugenol, volatile compounds with recognized mucolytic and anti-inflammatory properties in the airways, though no clinical trials have formally validated this specific traditional application.
What are the main bioactive compounds in Ocimum gratissimum?
Ocimum gratissimum contains eugenol (up to 76.01% of the essential oil in some chemotypes), thymol (up to 29.5%), and γ-terpinene (up to 20.5%) as dominant essential oil constituents, alongside phenolic acids including rosmarinic acid, caffeic acid, and chlorogenic acid, and flavonoids such as luteolin, quercetin, vicenin-2, rutin, and kaempferol. The relative proportions of these compounds vary significantly with geographic origin, harvest time, and chemotype, meaning that preparations from different regions can have substantially different pharmacological profiles.
Are there clinical trials supporting the health benefits of African basil (Ocimum gratissimum)?
As of the current literature, no randomized controlled trials or other human clinical studies have been published for Ocimum gratissimum in any indication; all available pharmacological evidence is derived from in vitro cell culture experiments and in vivo rodent models. Notable preclinical findings include antioxidant IC₅₀ values of 3.9 μg/mL (DPPH) for the essential oil and hepatoprotective effects at 0–40 mg/kg in CCl₄-injured rats, but these results cannot be directly translated to human therapeutic recommendations without further clinical investigation.
Is Ocimum gratissimum safe to use, and does it interact with medications?
Formal human safety data for Ocimum gratissimum are not established; preclinical rodent studies showed no overt toxicity at tested doses, but no maximum safe dose for humans has been defined. The high eugenol content in the essential oil raises theoretical concerns about interactions with anticoagulant drugs such as warfarin and antiplatelet agents like aspirin, since eugenol inhibits platelet aggregation; individuals on such medications should consult a healthcare provider before use. Pregnancy safety is unconfirmed, and the herb is prudently avoided during pregnancy given eugenol's potential uterotonic effects reported in related Ocimum species.
How do you prepare al-ruwag (scent leaf) as a home remedy?
The most common traditional preparation in Sudanese and West African practice involves steeping 5–10 g of fresh leaves in 250 mL of boiling water for 10–15 minutes to produce an herbal infusion consumed 1–2 times daily. For respiratory complaints specifically, steam inhalation is also practiced — fresh or dried leaves are added to a bowl of boiling water and the vapors inhaled under a towel for 5–10 minutes, leveraging the volatile eugenol and 1,8-cineole released during heating. No standardized supplemental dose or commercial encapsulated form has been validated through clinical trials.
What is the difference between al-ruwag (Ocimum gratissimum) and common basil (Ocimum basilicum)?
Al-ruwag (Ocimum gratissimum), also called African basil or scent leaf, has a spicier, more peppery aroma and contains different bioactive profiles compared to sweet basil (Ocimum basilicum), which is milder and more commonly used in cooking. Ocimum gratissimum contains higher concentrations of rosmarinic acid and vicenin-2, making it more valued in traditional medicine for antioxidant and respiratory applications, whereas common basil is primarily culinary. The two species are botanically distinct and have different traditional uses across African and Asian ethnomedicinal systems.
How should al-ruwag extract be dosed, and does preparation method affect potency?
Optimal dosing guidelines for al-ruwag have not been standardized in clinical practice; however, in vitro studies demonstrate bioactive effects at extract concentrations of 20–80 mg/mL, suggesting that more concentrated preparations may deliver measurable antioxidant benefits. Traditional preparation methods—such as steam inhalation, hot water infusion, or leaf decoction—affect the concentration and stability of heat-sensitive compounds like vicenin-2, with boiling potentially reducing volatile essential oil content compared to steeping. Until clinical dosage studies are completed, users should follow traditional preparation methods or consult practitioners familiar with al-ruwag use in their cultural context.
Who should avoid al-ruwag, and is it safe for pregnant women or nursing mothers?
Safety data specific to pregnancy and lactation are limited; therefore, pregnant and nursing women should consult healthcare providers before using al-ruwag supplements or concentrated extracts, as some herbal preparations may affect hormone levels or uterine contractions. Individuals with allergies to plants in the Lamiaceae family (mint family) or those taking anticoagulant medications should exercise caution, as rosmarinic acid may have mild antiplatelet properties at high doses. Children and the elderly should use al-ruwag under guidance, as age-specific safety and efficacy data are not yet established in clinical literature.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w al-ruwag-ocimum-gratissimum curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
